Vertex Pharmaceuticals Inc (VRTX)
Total asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 10,984,000 | 10,582,900 | 10,283,600 | 10,120,000 | 9,803,200 | 9,596,700 | 9,444,700 | 9,144,300 | 8,863,500 | 8,628,770 | 8,277,080 | 7,873,370 | 7,499,400 | 7,066,960 | 6,622,470 | 6,355,190 | 6,147,530 | 5,935,020 | 5,347,582 | 4,763,428 |
Total assets | US$ in thousands | 22,533,200 | 22,240,200 | 20,132,100 | 23,917,400 | 22,730,200 | 21,726,200 | 20,349,200 | 18,974,200 | 18,150,900 | 16,706,400 | 15,582,200 | 14,256,100 | 13,432,500 | 12,618,700 | 12,221,700 | 12,115,100 | 11,751,800 | 11,301,600 | 10,216,400 | 8,893,200 |
Total asset turnover | 0.49 | 0.48 | 0.51 | 0.42 | 0.43 | 0.44 | 0.46 | 0.48 | 0.49 | 0.52 | 0.53 | 0.55 | 0.56 | 0.56 | 0.54 | 0.52 | 0.52 | 0.53 | 0.52 | 0.54 |
December 31, 2024 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $10,984,000K ÷ $22,533,200K
= 0.49
The total asset turnover ratio of Vertex Pharmaceuticals Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The ratio ranged from a low of 0.42 in March 31, 2024, to a high of 0.56 in September 30, 2021, and December 31, 2021. This ratio measures the efficiency of the company in generating sales revenue from its investments in assets. A higher turnover ratio indicates that the company is utilizing its assets more effectively to generate revenue.
In the case of Vertex Pharmaceuticals Inc, the trend of the total asset turnover ratio generally declined from September 30, 2021, to June 30, 2024. The ratio decreased from 0.56 to 0.51 during this period, indicating a potential decrease in the company's efficiency in generating sales from its total assets. However, there was a slight uptick in the ratio in December 31, 2024, at 0.49, suggesting a possible improvement in asset utilization.
It is essential for Vertex Pharmaceuticals Inc to closely monitor its total asset turnover ratio to ensure optimal utilization of assets and maximize revenue generation. Further analysis and strategic adjustments may be necessary to improve the efficiency of the company's asset turnover in the future.
Peer comparison
Dec 31, 2024
See also:
Vertex Pharmaceuticals Inc Total Asset Turnover (Quarterly Data)